Recognizing and Managing Disordered Eating in Diabetes: What Clinicians Need to Know
Learn how to identify and manage disordered eating in type 1 and type 2 diabetes using ADA-recommended screening tools and multidisciplinary care strategies.
Leveling Up with Incretin Therapy: Expanding Benefits Beyond Diabetes, MACE, and Kidneys
Discover how GLP-1 receptor agonists like Semaglutide and Tirzepatide go beyond diabetes care—reducing sleep apnea severity, improving heart and kidney health, easing joint pain, and boosting endurance.
SGLT2 Inhibitors in Type 1 Diabetes – Where Do We Stand in 2025?
SGLT2 inhibitors have dramatically advanced the management of type 2 diabetes by reducing glycemia, cardiovascular events, and renal disease progression.